“The severe patients given SOC who advance to cr
Post# of 148175
Great point. I figure they have analyzed both populations by now, but maybe the larger cohort of sever patients (322) is taking longer to complete. If leronlimab could prove a stat sig reduction in progression from severe to critical, that would good enough for EUA. Let’s see what Monday morning brings.